Yang J - Search Results

1

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.

Shi Y, Jia B, Xu W, Li W, Liu T, Liu P, Zhao W, Zhang H, Sun X, Yang H, Zhang X, Jin J, Jin Z, Li Z, Qiu L, Dong M, Huang X, Luo Y, Wang X, Wang X, Wu J, Xu J, Yi P, Zhou J, He H, Liu L, Shen J, Tang X, Wang J, Yang J, Zeng Q, Zhang Z, Cai Z, Chen X, Ding K, Hou M, Huang H, Li X, Liang R, Liu Q, Song Y, Su H, Gao Y, Liu L, Luo J, Su L, Sun Z, Tan H, Wang H, Wang J, Wang S, Zhang H, Zhang X, Zhou D, Bai O, Wu G, Zhang L, Zhang Y. Shi Y, et al. Among authors: yang h, yang j. J Hematol Oncol. 2017 Mar 15;10(1):69. doi: 10.1186/s13045-017-0439-6. J Hematol Oncol. 2017. PMID: 28298231 Free PMC article.

2

[A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].

Lü SQ, Yang JM, Song XM, Chen L, Zhang WP, Ni X, Xu XQ, Wang JM. Lü SQ, et al. Zhonghua Zhong Liu Za Zhi. 2007 Sep;29(9):710-2. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18246806 Chinese.

3

Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experience.

Lü S, Wang J, Xu X, Ni X, Huang C, Qiu H, Hu X, Yang J. Lü S, et al. Among authors: yang j. Int J Hematol. 2009 Jan;89(1):34-38. doi: 10.1007/s12185-008-0218-9. Epub 2008 Dec 13. Int J Hematol. 2009. PMID: 19082817 Clinical Trial.

4

A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China.

Wang J, Lü S, Yang J, Song X, Chen L, Huang C, Hou J, Zhang W. Wang J, et al. Among authors: yang j. J Hematol Oncol. 2009 Jul 30;2:32. doi: 10.1186/1756-8722-2-32. J Hematol Oncol. 2009. PMID: 19642997 Free PMC article.

5

Allogeneic peripheral blood stem cell transplantation is a promising and safe choice for the treatment of refractory/relapsed acute myelogenous leukemia, even with a higher leukemia burden.

Zhang WP, Yang D, Song XM, Ni X, Chen J, Chen L, Yang JM, Zhou H, Cheng H, Liu BH, Li HM, Wang JM. Zhang WP, et al. Among authors: yang d, yang jm. Biol Blood Marrow Transplant. 2013 Apr;19(4):653-60. doi: 10.1016/j.bbmt.2013.01.015. Epub 2013 Jan 22. Biol Blood Marrow Transplant. 2013. PMID: 23353118 Free article.

6

FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome.

Wang L, Gao L, Xu S, Gong S, Chen L, Lü S, Chen J, Qiu H, Xu X, Ni X, Song X, Zhang W, Yang J, Liu M, Hu X, Wang J. Wang L, et al. Among authors: yang j. J Hematol Oncol. 2013 Nov 7;6(1):85. doi: 10.1186/1756-8722-6-85. J Hematol Oncol. 2013. PMID: 24517186 Free PMC article.

7

High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML).

Wang L, Gao L, Xu S, Gong S, Liu M, Qiu H, Xu X, Ni X, Chen L, Lu S, Chen J, Song X, Zhang W, Yang J, Hu X, Wang J. Wang L, et al. Among authors: yang j. Ann Hematol. 2014 Oct;93(10):1685-94. doi: 10.1007/s00277-014-2107-z. Epub 2014 May 21. Ann Hematol. 2014. PMID: 24844781

8

Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.

Xu XQ, Wang JM, Gao L, Qiu HY, Chen L, Jia L, Hu XX, Yang JM, Ni X, Chen J, Lü SQ, Zhang WP, Song XM. Xu XQ, et al. Among authors: yang jm. Am J Hematol. 2014 Sep;89(9):874-81. doi: 10.1002/ajh.23772. Epub 2014 Jun 19. Am J Hematol. 2014. PMID: 24861848 Free article.

9

[Comparative study on the efficacy of Hyper CVAD/MA regimen and CHOP or CHOP like regimen in the treatment of primary peripheral T cell lymphoma].

Wang J, Gao L, Qiu H, Zhang W, Yang J, Song X, Lyu S, Chen J, Wang J. Wang J, et al. Among authors: yang j. Zhonghua Xue Ye Xue Za Zhi. 2014 Oct;35(10):897-900. doi: 10.3760/cma.j.issn.0253-2727.2014.10.005. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25339325 Chinese.

10

Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.

Li R, Hu X, Wang L, Cheng H, Lv S, Zhang W, Wang J, Yang J, Song X. Li R, et al. Among authors: yang j. Am J Hematol. 2017 Jan;92(1):12-17. doi: 10.1002/ajh.24569. Epub 2016 Oct 21. Am J Hematol. 2017. PMID: 27673579 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,587 results

Search Page

Filters